2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 129 filers reported holding 2SEVENTY BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,304,999 | -32.5% | 1,353,316 | +74.1% | 0.00% | 0.0% |
| Q2 2023 | $7,864,465 | -33.8% | 777,121 | -33.3% | 0.00% | 0.0% |
| Q1 2023 | $11,886,325 | +495.3% | 1,165,326 | +446.8% | 0.00% | – |
| Q4 2022 | $1,996,738 | +135.2% | 213,099 | +265.6% | 0.00% | – |
| Q3 2022 | $849,000 | -69.5% | 58,291 | -72.3% | 0.00% | – |
| Q2 2022 | $2,781,000 | -59.1% | 210,721 | -47.1% | 0.00% | -100.0% |
| Q1 2022 | $6,796,000 | +127.8% | 398,404 | +242.4% | 0.00% | – |
| Q4 2021 | $2,983,000 | – | 116,358 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newtyn Management, LLC | 1,587,805 | $27,088,000 | 6.49% |
| CHI Advisors LLC | 819,672 | $13,984,000 | 5.95% |
| Madison Avenue Partners, LP | 896,972 | $15,302,342,000 | 2.86% |
| Bain Capital Life Sciences Investors, LLC | 1,408,901 | $24,036,000 | 2.33% |
| EcoR1 Capital, LLC | 3,495,943 | $59,641,000 | 1.87% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $5,118,000 | 1.02% |
| CVI Holdings, LLC | 819,672 | $13,984,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 2,000,000 | $34,120,000 | 0.66% |
| Altium Capital Management LP | 115,000 | $1,962,000 | 0.66% |
| Casdin Capital, LLC | 614,754 | $10,488,000 | 0.47% |